Nuvaira, Inc., a medical device company specializing in pulmonary interventions, obtained publication of European patent EP3949885A1 for a system for pulmonary treatment. The patent names inventors Mark Deem, Vivek Shenoy, and Martin L. Mayse, with primary classifications in A61B 18/18, A61B 18/12, and A61B 18/00 relating to surgical instruments using electricity. The patent is validated across all 44 designated EPC contracting states including Germany, France, UK, Italy, Spain, and other EU/EEA nations.

Medical device manufacturers and healthcare providers should note this patent grants Nuvaira exclusive rights to the claimed pulmonary treatment technology within European markets. Companies developing similar pulmonary treatment systems should conduct freedom-to-operate analyses to assess potential infringement risks. No immediate compliance actions are required as this is a patent grant publication rather than a regulatory requirement.